Clinical Trial Update: Pioglitazone for Heroin and for Nicotine Dependence [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluated pioglitazone for heroin dependence and nicotine dependence; the study was terminated and results were posted in July 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heroin Dependence
• Nicotine Dependence

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Heroin Dependence, Nicotine Dependence | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-07-13